Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00795054 · ClinicalTrials.gov registry record
The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family
A clinical trial, sponsored by Center for International Blood and Marrow Transplant Research.
- Completed
- Registry status
- 30
- Enrollment target
NCT00795054: Completed study, sponsored by Center for International Blood and Marrow Transplant Research.
NCT00795054 is a clinical trial that has completed, run by Center for International Blood and Marrow Transplant Research. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00795054 has completed, sponsored by Center for International Blood and Marrow Transplant Research.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to determine the feasibility of conducting a study of out-of-pocket costs and the long-term financial impact of allogeneic stem cell transplant.
Interventions
- OTHER Household financial data collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-03 |
| Est. Completion | 2015-08 |
What the finished NCT00795054 record still lists
NCT00795054 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Household financial data collection is the first listed.
NCT00795054 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00795054 about?
NCT00795054 is a clinical study titled "The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family". The purpose of this pilot study is to determine the feasibility of conducting a study of out-of-pocket costs and the long-term financial impact of allogeneic stem cell transplant.
What is the current status of trial NCT00795054?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2009-03. Estimated completion is 2015-08.
What interventions are being tested in trial NCT00795054?
The interventions under investigation include: Household financial data collection (OTHER).
Who is sponsoring clinical trial NCT00795054?
This trial is sponsored by Center for International Blood and Marrow Transplant Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia